Chicago Equity Partners’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | $425K | Sell |
4,730
-30,075
| -86% | -$2.7M | 0.04% | 470 |
|
|
2019
Q4 | $3.76M | Buy |
34,805
+18,225
| +110% | +$1.97M | 0.22% | 122 |
|
|
2019
Q3 | $1.62M | Buy |
16,580
+14,360
| +647% | +$1.41M | 0.08% | 370 |
|
|
2019
Q2 | $291K | Buy |
2,220
+160
| +8% | +$21K | 0.01% | 808 |
|
|
2019
Q1 | $278K | Sell |
2,060
-7,530
| -79% | -$1.02M | 0.01% | 775 |
|
|
2018
Q4 | $934K | Buy |
+9,590
| New | +$934K | 0.04% | 500 |
|
|
2017
Q4 | – | Sell |
-2,280
| Closed | -$320K | – | 857 |
|
|
2017
Q3 | $320K | Buy |
+2,280
| New | +$320K | 0.01% | 679 |
|
|
2015
Q2 | – | Sell |
-2,865
| Closed | -$497K | – | 535 |
|
|
2015
Q1 | $497K | Sell |
2,865
-100
| -3% | -$17.3K | 0.01% | 346 |
|
|
2014
Q4 | $549K | Sell |
2,965
-765
| -21% | -$142K | 0.01% | 311 |
|
|
2014
Q3 | $618K | Sell |
3,730
-5,845
| -61% | -$968K | 0.02% | 308 |
|
|
2014
Q2 | $1.5M | Sell |
9,575
-52,260
| -85% | -$8.17M | 0.04% | 244 |
|
|
2014
Q1 | $9.41M | Buy |
61,835
+59,360
| +2,398% | +$9.03M | 0.26% | 120 |
|
|
2013
Q4 | $328K | Sell |
2,475
-4,925
| -67% | -$653K | 0.01% | 351 |
|
|
2013
Q3 | $859K | Sell |
7,400
-250
| -3% | -$29K | 0.03% | 305 |
|
|
2013
Q2 | $705K | Buy |
+7,650
| New | +$705K | 0.02% | 322 |
|